Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review.
Journal
Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
10
06
2020
accepted:
16
08
2020
pubmed:
1
9
2020
medline:
29
12
2020
entrez:
1
9
2020
Statut:
ppublish
Résumé
Emerging evidence suggests that severe form of coronavirus disease 2019 (COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro- and macro-vascular thrombotic angiopathy. Although venous thrombotic events in COVID-19 patients have been well described, data on arterial thrombosis (AT) in these patients is still limited. We, therefore, conducted a rapid systematic review of current scientific literature to identify and consolidate evidence of AT in COVID-19 patients. A systematic search of literature was conducted between November 1, 2019, and June 9, 2020, on PubMed and China National Knowledge Infrastructure to identify potentially eligible studies. A total of 27 studies (5 cohort, 5 case series, and 17 case reports) describing arterial thrombotic events in 90 COVID-19 patients were included. The pooled incidence of AT in severe/critically ill intensive care unit-admitted COVID-19 patients across the 5 cohort studies was 4.4% (95% confidence interval 2.8-6.4). Most of the patients were male, elderly, and had comorbidities. AT was symptomatic in >95% of these patients and involved multiple arteries in approximately 18% of patients. The anatomical distribution of arterial thrombotic events was wide, occurring in limb arteries (39%), cerebral arteries (24%), great vessels (aorta, common iliac, common carotid, and brachiocephalic trunk; 19%), coronary arteries (9%), and superior mesenteric artery (8%). The mortality rate in these patients is approximately 20%. AT occurs in approximately 4% of critically ill COVID-19 patients. It often presents symptomatically and can affect multiple arteries. Further investigation of the underlying mechanism of AT in COVID-19 would be needed to clarify possible therapeutic targets.
Sections du résumé
BACKGROUND
BACKGROUND
Emerging evidence suggests that severe form of coronavirus disease 2019 (COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro- and macro-vascular thrombotic angiopathy. Although venous thrombotic events in COVID-19 patients have been well described, data on arterial thrombosis (AT) in these patients is still limited. We, therefore, conducted a rapid systematic review of current scientific literature to identify and consolidate evidence of AT in COVID-19 patients.
METHODS
METHODS
A systematic search of literature was conducted between November 1, 2019, and June 9, 2020, on PubMed and China National Knowledge Infrastructure to identify potentially eligible studies.
RESULTS
RESULTS
A total of 27 studies (5 cohort, 5 case series, and 17 case reports) describing arterial thrombotic events in 90 COVID-19 patients were included. The pooled incidence of AT in severe/critically ill intensive care unit-admitted COVID-19 patients across the 5 cohort studies was 4.4% (95% confidence interval 2.8-6.4). Most of the patients were male, elderly, and had comorbidities. AT was symptomatic in >95% of these patients and involved multiple arteries in approximately 18% of patients. The anatomical distribution of arterial thrombotic events was wide, occurring in limb arteries (39%), cerebral arteries (24%), great vessels (aorta, common iliac, common carotid, and brachiocephalic trunk; 19%), coronary arteries (9%), and superior mesenteric artery (8%). The mortality rate in these patients is approximately 20%.
CONCLUSIONS
CONCLUSIONS
AT occurs in approximately 4% of critically ill COVID-19 patients. It often presents symptomatically and can affect multiple arteries. Further investigation of the underlying mechanism of AT in COVID-19 would be needed to clarify possible therapeutic targets.
Identifiants
pubmed: 32866574
pii: S0890-5096(20)30767-6
doi: 10.1016/j.avsg.2020.08.087
pmc: PMC7453204
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
273-281Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Cureus. 2020 Mar 21;12(3):e7355
pubmed: 32328367
Thromb Haemost. 2020 Jun;120(6):998-1000
pubmed: 32316063
Clin Chim Acta. 2020 Aug;507:167-173
pubmed: 32348783
Br J Haematol. 2020 Jun;189(6):1053-1054
pubmed: 32353183
Rev Esp Cardiol. 2020 Aug;73(8):676-678
pubmed: 32405136
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E661-E666
pubmed: 32427416
Int J Environ Res Public Health. 2020 Apr 14;17(8):
pubmed: 32295188
PLoS Pathog. 2020 Apr 28;16(4):e1008520
pubmed: 32343745
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Curr Atheroscler Rep. 2014 Sep;16(9):435
pubmed: 25037581
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):342-7
pubmed: 11834539
Thromb Res. 2020 Aug;192:75-77
pubmed: 32425264
Thromb Haemost. 2020 May;120(5):876-878
pubmed: 32246450
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Biomed Pharmacother. 2020 Jul;127:110230
pubmed: 32428835
Hypertension. 2005 Feb;45(2):163-9
pubmed: 15630047
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
Crit Care. 2020 Jun 2;24(1):275
pubmed: 32487122
J Vasc Surg. 2020 Aug;72(2):756-757
pubmed: 32417015
Hematol Oncol Stem Cell Ther. 2021 Dec;14(4):348-350
pubmed: 32405288
Korean Circ J. 2014 Jul;44(4):250-4
pubmed: 25089137
Br J Haematol. 2020 Jun;189(6):1054-1056
pubmed: 32369614
J Vasc Surg. 2020 Dec;72(6):1864-1872
pubmed: 32360679
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Thromb Res. 2020 Jul;191:76-77
pubmed: 32402996
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Eur J Cancer. 2020 Jul;134:1-2
pubmed: 32454394
Int J Infect Dis. 2020 Jul;96:590-592
pubmed: 32447121
Semin Thromb Hemost. 2014 Sep;40(6):621-33
pubmed: 25099191
Front Immunol. 2017 Aug 31;8:1058
pubmed: 28912780
Nat Rev Immunol. 2020 Jul;20(7):389-391
pubmed: 32439870
Ann Vasc Surg. 2020 Aug;67:10-13
pubmed: 32474145
Circ Res. 2020 Apr 24;126(9):1297-1319
pubmed: 32324497
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Immun Ageing. 2008 Oct 23;5:12
pubmed: 18947391
J Neuroradiol. 2020 Sep;47(5):393-394
pubmed: 32389423
Eur J Case Rep Intern Med. 2020 Apr 30;7(5):001690
pubmed: 32399456
Can J Cardiol. 2020 Jul;36(7):1068-1080
pubmed: 32425328
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1377-84
pubmed: 18660448
J Vasc Surg. 2020 Aug;72(2):758-760
pubmed: 32361070
Lancet. 2020 May 16;395(10236):1546
pubmed: 32423583
Br J Haematol. 2020 Jul;190(1):e37-e38
pubmed: 32420614
Eur J Neurol. 2020 Sep;27(9):e38-e39
pubmed: 32503080
J Thromb Haemost. 2020 Jul;18(7):1738-1742
pubmed: 32302438
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Ann Vasc Surg. 2020 Jul;66:8-10
pubmed: 32360432
JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S62-72
pubmed: 22421232
Diagn Interv Imaging. 2020 May;101(5):321-322
pubmed: 32334995
Radiol Case Rep. 2020 Apr 29;15(7):1054-1057
pubmed: 32351657
Clin Med Insights Cardiol. 2015 Apr 19;8(Suppl 3):49-59
pubmed: 25983559
Intensive Care Med. 2020 Jul;46(7):1464-1465
pubmed: 32424482
J Pediatric Infect Dis Soc. 2018 May 15;7(2):151-158
pubmed: 28482105
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
AJNR Am J Neuroradiol. 2020 Jul;41(7):1170-1172
pubmed: 32409316
Pediatrics. 2007 Jan;119(1):e70-6
pubmed: 17130280